C
Cynthia H. Seow
Researcher at University of Calgary
Publications - 170
Citations - 5334
Cynthia H. Seow is an academic researcher from University of Calgary. The author has contributed to research in topics: Inflammatory bowel disease & Medicine. The author has an hindex of 32, co-authored 139 publications receiving 4331 citations. Previous affiliations of Cynthia H. Seow include University of Toronto & Mount Sinai Hospital.
Papers
More filters
Journal ArticleDOI
Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis.
TL;DR: For patients with ulcerative colitis treated with inflIXimab, a detectable trough serum infliximab predicts clinical remission, endoscopic improvement and a lower risk for colectomy.
Journal ArticleDOI
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
Geoffrey C. Nguyen,Cynthia H. Seow,Cynthia Maxwell,Vivian Huang,Yvette Leung,Jennifer Jones,Grigorios I. Leontiadis,Frances Tse,Uma Mahadevan,C. Janneke van der Woude,Alain Bitton,Brian Bressler,Sharyle Fowler,John Marshall,Carrie Palatnick,Anna Pupco,Joel G. Ray,Laura E. Targownik,Janneke van der Woude,William G. Paterson +19 more
TL;DR: Optimal management of IBD before and during pregnancy is essential to achieving favorable maternal and neonatal outcomes.
Journal ArticleDOI
Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus
Brian Bressler,John Marshall,Charles N. Bernstein,Alain Bitton,Jennifer Jones,Grigorios I. Leontiadis,Remo Panaccione,A. Hillary Steinhart,Francis Tse,Brian G. Feagan,Waqqas Afif,Edmond-Jean Bernard,Mark Borgaonkar,Shane M. Devlin,Richard N. Fedorak,Geoffrey C. Nguyen,Robert M Penner,Laurent Peyrin-Biroulet,Walter Reinisch,Cynthia H. Seow,Richmond Sy,Laura E. Targownik,Peter Thomson,Gert Van Assche,Chadwick Williams +24 more
TL;DR: Canadian consensus guidelines for the treatment of ambulatory patients with mild to severe active UC conclude that the goal of therapy is complete remission, defined as both symptomatic and endoscopic remission without corticosteroid therapy.
Journal ArticleDOI
Comparative Effectiveness of Immunosuppressants and Biologics for Inducing and Maintaining Remission in Crohn's Disease: A Network Meta-analysis
Glen Hazlewood,Ali Rezaie,Meredith A. Borman,Remo Panaccione,Subrata Ghosh,Cynthia H. Seow,Ellen Kuenzig,George Tomlinson,Corey A. Siegel,Gil Y. Melmed,Gilaad G. Kaplan +10 more
TL;DR: Adalimumab and infliximab + azathioprine are the most effective therapies for induction and maintenance of remission of Crohn's disease.
Journal ArticleDOI
Budesonide for induction of remission in Crohn's disease.
Ali Rezaie,M Ellen Kuenzig,Eric I Benchimol,Eric I Benchimol,Anne M. Griffiths,Anthony Otley,A. Hillary Steinhart,Gilaad G. Kaplan,Cynthia H. Seow +8 more
TL;DR: One study found budesonide to be superior to mesalamine for induction of clinical remission at 8 weeks, and the overall quality of the evidence for this outcome was moderate due to sparse data.